{"id":469296,"date":"2020-12-11T14:27:34","date_gmt":"2020-12-11T13:27:34","guid":{"rendered":"https:\/\/www.kapitalafrik.com\/?p=469296"},"modified":"2020-12-11T14:27:34","modified_gmt":"2020-12-11T13:27:34","slug":"major-failure-of-sanofi-in-the-development-of-its-vaccine","status":"publish","type":"post","link":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/","title":{"rendered":"Major failure of Sanofi in the development of its vaccine"},"content":{"rendered":"
<\/div>

French Sanofi announced on Friday a delay in the development program for its COVID-19 vaccine developed with the British GlaxoSmithKline (GSK) due to an insufficient immune response in the elderly, which is a major setback for the pharmaceutical group in the global race for a vaccine against the new coronavirus. \u201cThe results of the study do not live up to our expectations,\u201d GSK Vaccines President Roger Connor said in a statement.<\/p>\n

\u201cIn adults aged 18 to 49 years, the interim results of the phase I \/ II study showed an immune response comparable to that of patients who recovered from COVID-19 infection, but a weak immune response in older adults, potentially attributable to an insufficient concentration of antigens, \u201dthe two groups explained in a statement.<\/p>\n

Therefore, the two companies will launch a new phase IIb study which is expected to start in February 2021. If the data is positive, phase III – the final phase of development – would start in the second quarter of 2021. In case of positive results, the Submission of approval requests to regulatory authorities would take place in the second half of 2021, which will have the effect of pushing back the potential availability of the vaccine to the fourth quarter of 2021, which was originally scheduled for the start of the second half of 2021.<\/p>\n

\u201cThe strategy to be followed has been identified, and we are confident and firmly resolved to develop a safe and effective vaccine against COVID-19\u201d, declared Thomas Triomphe, executive vice-president and head of Sanofi Pasteur. The vaccine candidate developed by the two groups is based on the same classic technology used by Sanofi against seasonal influenza. It is associated with an adjuvant, a product intended to stimulate its action, developed by GSK.<\/p>\n

<\/div>","protected":false},"excerpt":{"rendered":"

French Sanofi announced on Friday a delay in the development program for its COVID-19 vaccine developed with the British GlaxoSmithKline (GSK) due to an insufficient immune response in the elderly, which is a major setback for the pharmaceutical group in the global race for a vaccine against the new coronavirus. \u201cThe results of the study<\/p>\n","protected":false},"author":527180,"featured_media":469297,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"pmpro_default_level":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"translated_post_url_fr":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[11996,12008],"tags":[16929,16930,16685],"class_list":{"0":"post-469296","1":"post","2":"type-post","3":"status-publish","4":"format-aside","5":"has-post-thumbnail","7":"category-finance-en","8":"category-stock-exchanges","9":"tag-major-failure-of-sanofi","10":"tag-sanofi","11":"tag-vaccine","12":"post_format-post-format-aside","13":"pmpro-has-access"},"yoast_head":"\nMajor failure of Sanofi in the development of its vaccine - Financial Afrik<\/title>\n<meta name=\"description\" content=\"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Major failure of Sanofi in the development of its vaccine\" \/>\n<meta property=\"og:description\" content=\"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Financial Afrik\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FinancialAfrik\/\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/pages\/Financial-Afrik\/150840631757446?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-11T13:27:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"696\" \/>\n\t<meta property=\"og:image:height\" content=\"392\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Financialafrik\" \/>\n<meta name=\"twitter:site\" content=\"@Financialafrik\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/person\\\/80f802fd6db958ac83d55076c6c93692\"},\"headline\":\"Major failure of Sanofi in the development of its vaccine\",\"datePublished\":\"2020-12-11T13:27:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/\"},\"wordCount\":294,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Sanofi-vaccin-696x392-1.jpg\",\"keywords\":[\"Major failure of Sanofi\",\"Sanofi\",\"vaccine\"],\"articleSection\":[\"Finance\",\"Stock Exchanges\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/\",\"name\":\"Major failure of Sanofi in the development of its vaccine - Financial Afrik\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Sanofi-vaccin-696x392-1.jpg\",\"datePublished\":\"2020-12-11T13:27:34+00:00\",\"description\":\"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2020\\\/12\\\/11\\\/major-failure-of-sanofi-in-the-development-of-its-vaccine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Sanofi-vaccin-696x392-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Sanofi-vaccin-696x392-1.jpg\",\"width\":696,\"height\":392},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/\",\"name\":\"Kapital Afrik\",\"description\":\"All African finance\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#organization\",\"name\":\"Kapital Afrik | All African finance\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.kapitalafrik.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-430x76-kapital-afrik-.png\",\"contentUrl\":\"https:\\\/\\\/www.kapitalafrik.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-430x76-kapital-afrik-.png\",\"width\":1740,\"height\":266,\"caption\":\"Kapital Afrik | All African finance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FinancialAfrik\\\/\",\"https:\\\/\\\/x.com\\\/Financialafrik\",\"https:\\\/\\\/www.instagram.com\\\/financialafrikbusiness\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/financial-afrik\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCSeoXcgLHLSVaKqMP7cQaJQ\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/person\\\/80f802fd6db958ac83d55076c6c93692\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c96a10dd5744a16de1cf5f4a5f23907a6d913e6ec3825c7447bb7a86e51e0a6d?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c96a10dd5744a16de1cf5f4a5f23907a6d913e6ec3825c7447bb7a86e51e0a6d?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c96a10dd5744a16de1cf5f4a5f23907a6d913e6ec3825c7447bb7a86e51e0a6d?s=96&d=blank&r=g\",\"caption\":\"Editor\"},\"description\":\"Kapital Afrik intends to deliver strategic financial information to executives and managers, through a daily newsletter and a website that covers all African finance.\",\"sameAs\":[\"http:\\\/\\\/financialafrik.com\",\"https:\\\/\\\/www.facebook.com\\\/pages\\\/Financial-Afrik\\\/150840631757446?fref=ts\"],\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/author\\\/admincfa\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Major failure of Sanofi in the development of its vaccine - Financial Afrik","description":"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"Major failure of Sanofi in the development of its vaccine","og_description":"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity","og_url":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/","og_site_name":"Financial Afrik","article_publisher":"https:\/\/www.facebook.com\/FinancialAfrik\/","article_author":"https:\/\/www.facebook.com\/pages\/Financial-Afrik\/150840631757446?fref=ts","article_published_time":"2020-12-11T13:27:34+00:00","og_image":[{"width":696,"height":392,"url":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_creator":"@Financialafrik","twitter_site":"@Financialafrik","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/#article","isPartOf":{"@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/"},"author":{"name":"Editor","@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/person\/80f802fd6db958ac83d55076c6c93692"},"headline":"Major failure of Sanofi in the development of its vaccine","datePublished":"2020-12-11T13:27:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/"},"wordCount":294,"commentCount":0,"publisher":{"@id":"https:\/\/www.financialafrik.com\/en\/#organization"},"image":{"@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg","keywords":["Major failure of Sanofi","Sanofi","vaccine"],"articleSection":["Finance","Stock Exchanges"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/","url":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/","name":"Major failure of Sanofi in the development of its vaccine - Financial Afrik","isPartOf":{"@id":"https:\/\/www.financialafrik.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/#primaryimage"},"image":{"@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg","datePublished":"2020-12-11T13:27:34+00:00","description":"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.financialafrik.com\/en\/2020\/12\/11\/major-failure-of-sanofi-in-the-development-of-its-vaccine\/#primaryimage","url":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg","contentUrl":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg","width":696,"height":392},{"@type":"WebSite","@id":"https:\/\/www.financialafrik.com\/en\/#website","url":"https:\/\/www.financialafrik.com\/en\/","name":"Kapital Afrik","description":"All African finance","publisher":{"@id":"https:\/\/www.financialafrik.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.financialafrik.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.financialafrik.com\/en\/#organization","name":"Kapital Afrik | All African finance","url":"https:\/\/www.financialafrik.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.kapitalafrik.com\/wp-content\/uploads\/2020\/06\/logo-430x76-kapital-afrik-.png","contentUrl":"https:\/\/www.kapitalafrik.com\/wp-content\/uploads\/2020\/06\/logo-430x76-kapital-afrik-.png","width":1740,"height":266,"caption":"Kapital Afrik | All African finance"},"image":{"@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FinancialAfrik\/","https:\/\/x.com\/Financialafrik","https:\/\/www.instagram.com\/financialafrikbusiness\/","https:\/\/www.linkedin.com\/in\/financial-afrik\/","https:\/\/www.youtube.com\/channel\/UCSeoXcgLHLSVaKqMP7cQaJQ\/"]},{"@type":"Person","@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/person\/80f802fd6db958ac83d55076c6c93692","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c96a10dd5744a16de1cf5f4a5f23907a6d913e6ec3825c7447bb7a86e51e0a6d?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c96a10dd5744a16de1cf5f4a5f23907a6d913e6ec3825c7447bb7a86e51e0a6d?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c96a10dd5744a16de1cf5f4a5f23907a6d913e6ec3825c7447bb7a86e51e0a6d?s=96&d=blank&r=g","caption":"Editor"},"description":"Kapital Afrik intends to deliver strategic financial information to executives and managers, through a daily newsletter and a website that covers all African finance.","sameAs":["http:\/\/financialafrik.com","https:\/\/www.facebook.com\/pages\/Financial-Afrik\/150840631757446?fref=ts"],"url":"https:\/\/www.financialafrik.com\/en\/author\/admincfa\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2020\/12\/Sanofi-vaccin-696x392-1.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/posts\/469296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/users\/527180"}],"replies":[{"embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/comments?post=469296"}],"version-history":[{"count":0,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/posts\/469296\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/media\/469297"}],"wp:attachment":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/media?parent=469296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/categories?post=469296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/tags?post=469296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}